Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Allergy Therapeutics Investors Focus on Clinical Progress and Funding Needs (LSE:AGY)

Allergy Therapeutics plc operates in allergy immunotherapy and vaccine development.

Ankur Sharma | 19 October 2026

Cambridge Nutritional Sciences: Can Test Demand Support Sustainable Growth? (LSE:CNSL)

Cambridge Nutritional Sciences PLC (LSE:CNSL) sits in the healthcare category, with exposure to diagnostic testing for food intolerance and related health applications.

Ankur Sharma | 19 October 2026

Eden Biosolutions: Product Validation and Commercialisation in Focus (LSE:EDEN)

Eden Biosolutions is a development-focused healthcare and biosolutions story. Investors monitor product validation, regulatory progress, commercial partnerships, cash runway and the path to recurring sales. No specific fresh catalyst was verified.

Ankur Sharma | 19 October 2026

Eden Biosolutions PLC (LSE:EDEN): What Could Drive the Next Move as Investors Track Key Milestones?

• Eden Biosolutions PLC (LSE:EDEN) is being assessed against its next operational and financial milestones.

Ankur Sharma | 19 October 2026

Faron Pharmaceuticals: Clinical Evidence and Funding Remain Decisive (LSE:FARN)

Faron Pharmaceuticals Oy (LSE:FARN) sits in the healthcare category, with exposure to clinical-stage immunotherapy and oncology drug development.

Ankur Sharma | 19 October 2026

Futura Medical plc (LSE:FUM): What Could Drive the Next Move as Investors Track Key Milestones?

• Futura Medical plc (LSE:FUM) is being assessed against its next operational and financial milestones.

Ankur Sharma | 19 October 2026

Genedrive Plc (LSE:GDR): What Could Drive the Next Move as Investors Track Key Milestones?

• Key focus: Diagnostic test adoption, clinical evidence and commercial funding.

Ankur Sharma | 19 October 2026

How Creo Medical Brings Surgical Endoscopy Innovation to the FTSE AIM All Share Index

Creo Medical, which is based in Wales, develops surgical devices that combine bipolar radiofrequency energy for cutting with microwave energy for coagulation. Its technology platform, delivered through a dedicated electrosurgical generator, is designed to power a range of flexible instruments that can be passed …

Divya Sood | 19 October 2026

How CRISM Therapeutics is targeting localised chemotherapy as a life sciences name on the FTSE AIM All Share Index

CRISM's lead product, ChemoSeed, is designed to be implanted directly into a tumour or into the resection margin after a tumour has been surgically removed, releasing chemotherapy locally rather than throughout the body. The company's initial focus has been on brain tumours, which are …

Divya Sood | 19 October 2026

Why Craneware remains a heavyweight healthcare software name on the FTSE AIM All Share Index

Craneware develops software and data analytics that help US healthcare providers manage revenue, costs and operational performance. Its customers are mainly hospitals and health systems in the United States, where complex billing, reimbursement and regulatory rules make revenue integrity a significant challenge. The company's …

Divya Sood | 19 October 2026
Support

Hi! How can we help you today?

Loading…